Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working Party-Reference-Cited by-同舟云学术

Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working Party

Published:2012-06 Issue:6 Volume:23 Page:1499-1502
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

D'Arena G.,Valentini C.G.,Pietrantuono G.,Guariglia R.,Martorelli M.C.,Mansueto G.,Villani O.,Onofrillo D.,Falcone A.,Specchia G.,Semenzato G.,Di Renzo N.,Mastrullo L.,Venditti A.,Ferrara F.,Palumbo A.,Pagano L.,Musto P.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/23/6/1499/402367/mdr480.pdf

Reference38 articles.

1. Plasma cell leukaemia and other aggressive plasma cell malignancies;Sher;Br J Haematol,2010

2. Plasma cell leukemia;Albarracin;Blood Rev,2011

3. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group;International Myeloma Working Group;Br J Haematol,2003

4. Plasma cell neoplasms;McKenna,2008

5. Plasma cell leukaemia: an evaluation of response to therapy;Noel;Am J Med,1987

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Status on Management of Primary Plasma Cell Leukemia;Current Oncology Reports;2024-07-02

2. Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study;The Lancet Oncology;2023-10

3. Clinical observation of a 64-year-old female patient with plasma cell leukemia diagnosed during coronavirus infection COVID-19;MD-Onco;2022-10-13

4. Comparison of autologous and allogeneic hematopoietic cell transplantation strategies in patients with primary plasma cell leukemia, with dynamic prediction modeling;Haematologica;2022-06-30

5. Plasma cell leukemia: Retrospective review of cases at Monter Cancer Center/Northwell Health Cancer Institute, 2014-2019;Current Problems in Cancer;2022-06